A drug approved in 2019 for macular degeneration apparently caused rare retinal side effects because of its interactions with the human immune system, two new studies have concluded.
The human brain consumes vast amounts of energy, which is almost exclusively generated from a form of metabolism that requires oxygen. While the efficient and timely delivery of oxygen is known to be critical to healthy brain ...
Mar 28, 2024
0
30
A research team at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has succeeded in establishing a model of the blood-brain barrier using modularized tissue derived from human cells. The "Tissue-in-a-CUBE" ...
Feb 28, 2024
0
14
The same property of thalidomide that caused birth defects when it was given to pregnant women—the inhibition of blood vessel formation (anti-angiogenesis)—has led to an interest in thalidomide's therapeutic utility in ...
Jun 10, 2022
0
83
You have just enjoyed a delicious summer BBQ. After approximately eight hours, food molecules reach your small intestine, where specialized lymph capillaries, called lacteals, absorb fat nutrients. Lacteals are different ...
Aug 14, 2020
0
72
Can obesity define health? It is a question for much debate. Still, obesity is generally classified into metabolically healthy obesity (MHO) and an unhealthy version of obesity. As we grow older, we tend to put on excess ...
Jun 24, 2020
0
48
Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to clogged ...
May 15, 2013
0
0
Scientific collaborators from Yale School of Medicine and University College London (UCL) have uncovered the molecular pathway by which new arteries may form after heart attacks, strokes and other acute illnesses bypassing ...
Apr 29, 2013
0
3
(Medical Xpress)—Using a super-resolution fluorescent microscope, medical scientists are a step closer to understanding why and how human immune cells decide to activate or not, thus enabling or preventing disease taking ...
Dec 3, 2012
0
0
A new editorial paper titled "Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma" has been published in Oncotarget.
Sep 20, 2023
0
1
